lmciccone
Team TFS
Team TFS
since ‎02-21-2022
‎01-31-2023

User Statistics

  • 1 Posts
  • 0 Solutions
  • 9 Kudos given
  • 3 Kudos received

User Activity

REGISTER HERE The field of mass spectrometry has advanced tremendously over the last decade on both the hardware as well as the software side. Nevertheless, we still do not use the full capacity of the acquired proteomic data and several layers of in...
REGISTER HERE NEW DATE AND TIME! REGISTER NOW. Workflows for the analysis oligonucleotides by high resolution LCMS to support therapeutic drug development can often cover a wide range of modalities, ranging from heavily modified sequences to very lar...
The market of biologics in Biopharma companies is in constant evolution and moved away in the last few years from classical monoclonal antibody to proteins that are more difficult to analyze, such as therapeutics proteins, antibody drug/molecule conj...
The market of biologics in Biopharma companies is in constant evolution and moved away in the last few years from classical monoclonal antibody to proteins that are more difficult to analyze, such as therapeutics proteins, antibody drug/molecule conj...
In the development of biotherapeutics, a thorough understanding of a molecule’s product quality attributes (PQAs), and their effect on various structure-function relationships and long-term stability, is essential for ensuring the safety and efficacy...
Kudos given to